2022_Oct_PDA_Universe_CA_skyscraper

advanced search
2022_Oct_PDA_Universe_CA_leaderboard

INDUSTRIALISING DRUG DELIVERY89

Issue No #89  August 13th, 2018


Download PDF


Inside the magazine

ORAL THIN FILMS: NOVEL TECHNOLOGY & ITS CHALLENGES
EXPERT VIEW
Dr Nidhi Prakash Sapkal
ORAL THIN FILMS: NOVEL TECHNOLOGY & ITS CHALLENGES
Presented from both the technology and formulation perspectives, Nidhi Prakash Sapkal and Anwar Siraj Daud discuss the challenges of industrialising oral thin films, a promising but difficult dosage form.
BEYOND MANUFACTURING: INDUSTRIALISATION OF DRUG DELIVERY IN THE REAL WORLD
EXPERT VIEW
Napoleon Monroe
BEYOND MANUFACTURING: INDUSTRIALISATION OF DRUG DELIVERY IN THE REAL WORLD
When discussing the industrialisation of drug delivery, it is natural to focus on the processes and management of manufacture. Napoleon Monroe provides a different perspective on the idea of drug delivery’s “Industrialisation” and what that might mean in the modern world of service industry.
INDUSTRIALISING DRUG DELIVERY SYSTEMS – A RISK-BASED APPROACH
INDUSTRIALISATION
Catherine Thacker
ATS Automation
INDUSTRIALISING DRUG DELIVERY SYSTEMS – A RISK-BASED APPROACH
Catherine Thacker and Tom Hayes discuss ATS Automation’s methodology for developing a manufacturing strategy for a drug delivery device, from fresh design to mass-produced product.
MEASURING THE INFLUENCE OF TALC ON THE PROPERTIES OF LACTOSE POWDERS
INDUSTRIALISATION
Dr Quentin Ribeyre
Granutools
MEASURING THE INFLUENCE OF TALC ON THE PROPERTIES OF LACTOSE POWDERS
Quentin Ribeyre et al describe how three of the company’s instruments can be used to characterise powder properties and behaviour, exemplified by experiments investigating the effects of adding talc to different lactose grades.
THE BIGGEST MISTAKES COMPANIES MAKE COMMERCIALISING DRUG DELIVERY – AND WHAT TO DO ABOUT THEM
EXPERT VIEW
Beth Blackburn
THE BIGGEST MISTAKES COMPANIES MAKE COMMERCIALISING DRUG DELIVERY – AND WHAT TO DO ABOUT THEM
It is difficult to successfully scale-up a product to industrial production and launch, but it is much harder if design fundamentals are not adhered to. Beth Blackburn details the need for setting down requirements early in device development in order to avoid inadvertently undermining a product’s successful commercialisation.
A “KODAK” MOMENT FOR THE PHARMA INDUSTRY?
EXPERT VIEW
Dr Pari Datta
A “KODAK” MOMENT FOR THE PHARMA INDUSTRY?
Pari Datta and Nick Rollings discuss the concept of personalised medicine, with particular reference to oncology, and how it represents both an opportunity and a threat.
A COMPREHENSIVE APPROACH TO PHARMA INDUSTRIALISATION PARTNERING
INDUSTRIALISATION
Michael Wiglenda
Gerresheimer
A COMPREHENSIVE APPROACH TO PHARMA INDUSTRIALISATION PARTNERING
As a company offering contract services at every stage of drug delivery system development, Gerresheimer has a wealth of expertise and history in industrial-scale production. Michael Wiglenda explains Gerresheimer’s industrialisation offering in detail.
KEY CONSIDERATIONS FOR ACCURATE QUANTIFICATION OF SUB-MICRON PARTICLES IN PHARMACEUTICALS
INDUSTRIALISATION
Dr Jean-Luc Fraikin
Spectradyne
KEY CONSIDERATIONS FOR ACCURATE QUANTIFICATION OF SUB-MICRON PARTICLES IN PHARMACEUTICALS
Jean-Luc Fraikin discusses the use of resistive pulse sensing as a method to characterise nanoparticles in biologic formulations. Spectradyne has developed a new implementation of this technique, MPRS, that makes it a practical analytical method for industrial pharmaceutical applications.
THE ODTECH PLATFORM: A RANGE OF READY-TO-USE ORAL FORMS
INDUSTRIALISATION
Hugues Benevent
Unither Pharmaceuticals
THE ODTECH PLATFORM: A RANGE OF READY-TO-USE ORAL FORMS
Hugues Benevent and Nathalie Masson introduce the ODtech™ platform technology for oral medications, designed to provide an easy-to-use and ready-to-industrialise solution for tackling the human factors issues of standard oral pills.
MANAGING RISKS & COSTS FOR SEAMLESS SCALE-UP & SMOOTH COMMERCIALISATION
INDUSTRIALISATION
Simon Strothers
3P Innovation
MANAGING RISKS & COSTS FOR SEAMLESS SCALE-UP & SMOOTH COMMERCIALISATION
Today’s drug delivery industry is seeing shifting thought in a number of areas, one of which is the move towards design for manufacture. Simon Strothers and Dave Seaward both of 3P innovation, discuss a “better way” for developing drug delivery devices, highlighting design for manufacture, critical quality concerns and mandraulic prototyping.
INTEGRATING CONNECTED HEALTH IN RESPIRATORY: THE MANUFACTURING CHALLENGE
EXPERT VIEW
David Belton
INTEGRATING CONNECTED HEALTH IN RESPIRATORY: THE MANUFACTURING CHALLENGE
David Belton highlights an often undiscussed aspect of the move towards connected drug delivery devices, the impact on manufacturing. Using inhalers as a reference point, he runs through several of the concerns and decisions that will need to be addressed for successful mass production of such devices.
THE NEED FOR A RELIABLE SUPPLY-CHAIN & HOW TO CREATE IT STRATEGICALLY
EXPERT VIEW
Antonio Teglia
THE NEED FOR A RELIABLE SUPPLY-CHAIN & HOW TO CREATE IT STRATEGICALLY
Antonio Teglia and Devon McCrossin discuss the increased importance of proper supply-chain management when it comes to mitigating the inherent production risks of today’s increasingly complex drug delivery devices.
ELECTROSPINNING: A PROMISING APPROACH TO CONTINUOUS MANUFACTURING FOR PHARMACEUTICALS
EARLY INSIGHT
Dr Blair Brettmann
Georgia Institute of Technology
ELECTROSPINNING: A PROMISING APPROACH TO CONTINUOUS MANUFACTURING FOR PHARMACEUTICALS
Blair Brettmann discusses the present advantages and challenges, as well as the future potential, of electrospinning as a continuous manufacturing technique for the pharmaceutical industry.
TORSTEN MASCHKE, DATWYLER SEATLING SOLUTIONS
INTERVIEW
Torsten Maschke
TORSTEN MASCHKE, DATWYLER SEATLING SOLUTIONS
Torsten Maschke discusses the industrialisation of drug delivery, from the perspective of an industrialisation specialist partner for the pharmaceutical industry, looking at the trends in the field today and the advantages of the modern paradigm of partnering.
GO WITH THE FLOW – SOLVING POWDER FLOW CHALLENGES BEFORE PRODUCTION
EXPERT VIEW
Jonathan Gaik
GO WITH THE FLOW – SOLVING POWDER FLOW CHALLENGES BEFORE PRODUCTION
Jonathan Gaik discusses the various problems in tablet compression that can be caused by not giving due care to powder flow in the development stage and how, by doing so, what would be serious problems at the industrial scale can be solved in advance.
GAS PLASMA PROCESSING: A LONG-TERM SOLUTION FOR RESPIRATORY DEVICES
INDUSTRIALISATION
Ameet Sule
H&T Presspart
GAS PLASMA PROCESSING: A LONG-TERM SOLUTION FOR RESPIRATORY DEVICES
Ameet Sule, Head of H&T Presspart’s Inhalation Product Technology Centre (IPCT), discusses the new challenges arising in metered dose inhaler design since the change from CFC to HFA propellants.
DEVICE MANUFACTURING FROM DEVELOPMENT THROUGH COMMERCIALISATION
INDUSTRIALISATION
Sheleagh O'Neil
SMC Ltd.
DEVICE MANUFACTURING FROM DEVELOPMENT THROUGH COMMERCIALISATION
Sheleagh Dougan and Meredith Canty give an overview of the scales of manufacturing throughout the design of a new combination product and the necessary considerations at each one.
THE CHALLENGES OF MANUFACTURING COMBINATION COMPONENTS
INDUSTRIALISATION
Bob Parsons
ProMed Pharma
THE CHALLENGES OF MANUFACTURING COMBINATION COMPONENTS
Bob Parsons and Jim Arps discuss three significant challenges faced by companies looking to manufacture components for combination products in the medical sector and how ProMed has risen to meet them.
Top